Science, ethics, and the future of research into maternal infant transmission of HIV-1

Lancet

Volumn 353, Issue 9155, 1999, Pages 832-835

  Wilfert, Catherine ^a  

^a ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

BREAST FEEDING; COMPARATIVE STUDY; DEVELOPING COUNTRY; DISEASE TRANSMISSION; ETHICS; FEMALE; FETUS; HEALTH CARE; HEALTH CARE MANAGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; INTRAVENOUS DRUG ADMINISTRATION; LABOR; MEDICAL RESEARCH; NEWBORN; ORAL DRUG ADMINISTRATION; PERINATAL INFECTION; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; SHORT SURVEY; THAILAND; BIOMEDICAL AND BEHAVIORAL RESEARCH; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; MEDICAL ETHICS; METHODOLOGY; PERINATAL HIV INTERVENTION RESEARCH IN DEVELOPING COUNTRIES WORKSHOP; SCIENCE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; PERINATAL HIV INTERVENTION RESEARCH IN DEVELOPING COUNTRIES WORKSHOP;

DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; ETHICS, MEDICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; RESEARCH DESIGN; SCIENCE;

EID: 0033528548     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)10414-2     Document Type: Note

References (23)

1. 1997 year-end edition, HIV/AIDS surveillance report. Centers for Disease Control and Prevention, US Department of Health and Human Services, Public Health Service, Atlanta, GA. 1998; 9: 1-43.
2. Davis SF, Byers RH, Lindegren ML, et al. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 1995; 247: 952-55.
3. Prevention of HIV transmission from mother-to-child: planning for programme implementation. UNAIDS, World Health Organization, Geneva, Switzerland: March 23-24, 1998.
4. Centers for Disease Control. Update: perinatally acquired HIV/AIDS-United States, 1997. MMWR 1997; 46: 1086-92.
5. Centers for Disease Control. Public health service task force recommendations for the use of antiretroviral drugs in pregnant women infected with human immunodeficiency virus-1 for maternal health and for reducing perinatal HIV-1 transmission in the US. MMWR 1998; 47 (suppl RR-2): 1-30.
6. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of HIV type 1 with ZDV treatment. N Engl J Med 1994; 331: 1173-80.
7. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Importance of maternal ZDV therapy in the reduction of perinatal transmission of HIV: abstracts of the 4th Conference on Retroviruses and Opportunistic Infections. Washington DC: Jan 22-29, 1997: abstr 379.
8. Birkhead GS, Warren BL, Charbonneau TT, et al. Evidence for intermediate rates of perinatal HIV transmission with partial 076 regimens: results of an observational study. Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. Chicago, IL: Feb 1-5, 1998: abstr 244.
9. Mayaux M-J, Teglas J-P, Mandelbrot L, et al. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus type 1 transmission in France. J Pediatr 1997; 131: 857-62.
10. Mofenson L, Stiehm ER, Lambert J, et al. Efficacy of ZDV in reducing perinatal HIV-1 tranmission in HIV-1 infected women with advanced disease (abstr). In: Proceedings of 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada: September 1997; abstr I-117.
11. Centers for Disease Control. Administration of ZDV during late pregnancy and delivery to prevent perinatal HIV transmission -Thailand. MMWR 1998; 47: 151-54.
12. Culnane M, Fowler MG, Lee S, et al. Evaluation for late effects of in utero (IU) ZDV exposure among uninfected infants born to HIV positive women enrolled in 076 and 219. Clin Infect Dis 1997; 25 (abstr).
13. World Bank Sector Strategy Health, Nutrition, and Population, 1997.
14. HIV and infant feeding. UN Children's Fund. UNAIDS. WHO: June, 1998.
15. Council of International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO): International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: CIOMS, 1993.
16. De Zoysa I, Elias CJ, Bently ME. Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention. Am J Public Health 1998; 88: 571-75.
17. Karim SSA. Placebo controls in HIV perinatal transmission trials: a South African's viewpoint. Am J Public Health 1998; 88: 564-66.
18. Bayer R. Research to prevent maternal fetal transmission of HIV: racist exploitation or exploitation of racism? Am J Public Health 1998; 88: 567-70.
19. Susser M. Editor's note: the prevention of perinatal HIV transmission in the less developed world. Am J Public Health 1998; 88: 547-48.
20. Faden R, Kass N. Editorial: HIV research, ethics, and the developing world. Am J Public Health 1998; 88: 548-50.
21. Bloom BR. The highest attainable standard: ethical issues in AIDS vaccines. Science 1998; 279: 186-88.
22. Levine RJ. The "Best Proven Therapeutic Method" standard in clinical trials in technologically developing countries: IRB, 1998: a review of human subjects research: 20 (number 1): 5-9.
23. Pragmatism in codes of research ethics (editorial). Lancet 1998; 351: 225.